Ayal is a Professor at the Institute for Nanotechnology and Advanced Materials, The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, bringing extensive expertise in genome engineering and DNA repair. He earned his PhD in Biochemistry from the Weizmann Institute of Science and completed postdoctoral training in genome engineering at Stanford University School of Medicine. As head of a research lab developing safe and effective CRISPR-based therapies for monogenic diseases and cancer, he leads efforts toadvance methods that rigorously assess and improve the precision of gene editing by detecting and minimizing off-target effects.